Warner Carr

3.1k total citations
35 papers, 814 citations indexed

About

Warner Carr is a scholar working on Immunology and Allergy, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Warner Carr has authored 35 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology and Allergy, 16 papers in Physiology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Warner Carr's work include Allergic Rhinitis and Sensitization (22 papers), Asthma and respiratory diseases (16 papers) and Food Allergy and Anaphylaxis Research (9 papers). Warner Carr is often cited by papers focused on Allergic Rhinitis and Sensitization (22 papers), Asthma and respiratory diseases (16 papers) and Food Allergy and Anaphylaxis Research (9 papers). Warner Carr collaborates with scholars based in United States, Belgium and France. Warner Carr's co-authors include David Price, Eli O. Meltzer, Phil Lieberman, Claus Bachert, Ullrich Munzel, Jean Bousquet, Jonathan A. Bernstein, Paul H. Ratner, Bryan Martin and Craig LaForce and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and European Journal of Neurology.

In The Last Decade

Warner Carr

32 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Warner Carr United States 13 653 490 253 160 140 35 814
Caterina Pronzato Italy 14 836 1.3× 833 1.7× 271 1.1× 70 0.4× 246 1.8× 26 1.0k
Radosław Gawlik Poland 13 379 0.6× 313 0.6× 155 0.6× 30 0.2× 136 1.0× 71 614
E. Rijntjes Netherlands 19 662 1.0× 639 1.3× 131 0.5× 120 0.8× 268 1.9× 28 983
Lawrence M. Lichtenstein United States 13 454 0.7× 489 1.0× 137 0.5× 48 0.3× 125 0.9× 15 731
R. Fadel France 14 859 1.3× 841 1.7× 431 1.7× 35 0.2× 188 1.3× 27 1.0k
Philipp Badorrek Germany 12 318 0.5× 283 0.6× 211 0.8× 38 0.2× 91 0.7× 33 498
Marcy deTineo United States 16 556 0.9× 496 1.0× 81 0.3× 165 1.0× 120 0.9× 24 647
Marcello Montagni Italy 12 312 0.5× 205 0.4× 125 0.5× 17 0.1× 60 0.4× 34 466
David Proud United States 10 214 0.3× 288 0.6× 37 0.1× 97 0.6× 136 1.0× 13 443
F.A. Romero United States 10 286 0.4× 420 0.9× 53 0.2× 33 0.2× 222 1.6× 21 573

Countries citing papers authored by Warner Carr

Since Specialization
Citations

This map shows the geographic impact of Warner Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warner Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warner Carr more than expected).

Fields of papers citing papers by Warner Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warner Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warner Carr. The network helps show where Warner Carr may publish in the future.

Co-authorship network of co-authors of Warner Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Warner Carr. A scholar is included among the top collaborators of Warner Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warner Carr. Warner Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walter, Uwe, Philipp Albrecht, Warner Carr, & Harald Hefter. (2025). Systematic Review and Meta‐Analysis of Secondary Treatment Failure and Immunogenicity With Botulinum Neurotoxin A in Multiple Indications. European Journal of Neurology. 32(8). e70289–e70289. 2 indexed citations
2.
Chipps, Bradley E., Njira Lugogo, Warner Carr, et al.. (2024). On-treatment clinical remission of severe asthma with real-world longer-term biologic use. Journal of Allergy and Clinical Immunology Global. 4(1). 100365–100365.
3.
Kim, Edwin, Warner Carr, Amal Assa’ad, et al.. (2024). ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trial. Journal of Allergy and Clinical Immunology Global. 4(1). 100382–100382.
4.
Carr, Warner, Carla M. Davis, David M. Fleischer, et al.. (2023). Immune response evolution in peanut epicutaneous immunotherapy forpeanut‐allergicchildren. Allergy. 78(9). 2467–2476. 7 indexed citations
5.
Wasserman, Richard L., Douglas H. Jones, Hugh H. Windom, et al.. (2019). Reaching for best practices in food oral immunotherapy. Annals of Allergy Asthma & Immunology. 123(2). 129–130.e3. 11 indexed citations
6.
Cavet, Megan E., Paul J Gomes, Warner Carr, & Jon I. Williams. (2018). Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis. Journal of Asthma and Allergy. Volume 11. 29–39. 4 indexed citations
7.
Carr, Warner & Stanley J. Szefler. (2016). Inhaled corticosteroids. Annals of Allergy Asthma & Immunology. 117(6). 589–594. 9 indexed citations
8.
Bousquet, Jean, Claus Bachert, Jonathan A. Bernstein, et al.. (2015). Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps. Expert Opinion on Pharmacotherapy. 16(6). 913–928. 25 indexed citations
9.
Meltzer, Eli O., Paul H. Ratner, Claus Bachert, et al.. (2013). Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis. International Archives of Allergy and Immunology. 161(4). 369–377. 84 indexed citations
10.
Carr, Warner. (2013). Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations. Pediatric Drugs. 15(4). 303–310. 132 indexed citations
11.
Price, David, Shailen Shah, Sanjay Bhatia, et al.. (2013). A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.. PubMed. 23(7). 495–503. 67 indexed citations
12.
Bousquet, Jean, Warner Carr, Jonine L. Bernstein, et al.. (2012). MP29-02 is effective for the symptomatic treatment of seasonal allergic rhinitis even in those with very severe disease: a meta-analysis. Allergy. 67. 336–336. 1 indexed citations
13.
Carr, Warner, Jonathan A. Bernstein, Phil Lieberman, et al.. (2012). A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. Journal of Allergy and Clinical Immunology. 129(5). 1282–1289.e10. 147 indexed citations
14.
Carr, Warner, Paul H. Ratner, Ullrich Munzel, et al.. (2012). Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis. Allergy and Asthma Proceedings. 33(6). 450–458. 20 indexed citations
15.
LaForce, Craig, Warner Carr, Stephen A. Tilles, et al.. (2010). Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis. Allergy and Asthma Proceedings. 31(2). 132–140. 10 indexed citations
16.
Carr, Warner. (2008). Pediatric allergic rhinitis: Current and future state of the art. Allergy and Asthma Proceedings. 29(1). 14–23. 4 indexed citations
17.
Yoon, In‐Kyu, Bryan Martin, & Warner Carr. (2006). A comparison of two single-headed and two multi-headed allergen skin test devices. Allergy and Asthma Proceedings. 27(6). 473–478. 8 indexed citations
18.
Carr, Warner, Bryan Martin, Robin Howard, Linda Cox, & Larry Borish. (2005). Comparison of test devices for skin prick testing. Journal of Allergy and Clinical Immunology. 116(2). 341–346. 47 indexed citations
20.
Carr, Warner, et al.. (1999). The Role of Endomyocardial Biopsy in the Diagnosis and Treatment of Churg-Strauss Syndrome. JCR Journal of Clinical Rheumatology. 5(2). 79–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026